Complex Factors in Hydrocephalus Development in Tuberous Sclerosis Complex: A Case Report of Subependymal Giant Cell Astrocytoma

被引:0
作者
Nakamura, Hajime [1 ]
Izumi, Masaki [2 ]
Omori, Yoshinori [2 ]
Numoto, Shingo [3 ]
Fujimoto, Ayataka [2 ]
机构
[1] Seirei Hamamatsu Gen Hosp, Neurosurg, Hamamatsu, Japan
[2] Seirei Hamamatsu Gen Hosp, Ctr Epilepsy & Funct Neurol, Hamamatsu, Japan
[3] Seirei Hamamatsu Gen Hosp, Pediat Neurol, Hamamatsu, Japan
关键词
Categories; Neurosurgery; Surgery; Oncology tuberous sclerosis complex (tsc); mammalian target of rapamycin (mtor) inhibitor; surgical removal; hydrocephalus; subependymal giant cell astrocytoma (sega);
D O I
10.7759/cureus.65132
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC) occurs in 520% of TSC patients, with a subset developing hydrocephalus. We present a case of a 14-year-old male diagnosed with TSC in the neonatal period who developed SEGA and subsequent hydrocephalus. Despite reducing the tumor size with the mammalian target of rapamycin (mTOR) inhibitors, ventricular enlargement persisted, indicating that obstructive hydrocephalus due to the foramen of Monro blockage was not the sole mechanism. Elevated cerebrospinal fluid (CSF) protein levels suggested additional factors like impaired CSF outflow. This case underscores the need for comprehensive treatment strategies and further research to better understand and manage hydrocephalus in TSC patients with SEGA.
引用
收藏
页数:4
相关论文
共 17 条
  • [1] A Comparison of Clinical Outcomes for Subependymal Giant Cell Astrocytomas Treated with Laser Interstitial Thermal Therapy, Open Surgical Resection, and mTOR Inhibitors
    Boop, Scott
    Bonda, David
    Randle, Stephanie
    Leary, Sarah
    Vitanza, Nicholas
    Crotty, Erin
    Novotny, Edward
    Friedman, Seth
    Ellenbogen, Richard G. G.
    Durfy, Sharon
    Goldstein, Hannah
    Ojemann, Jeffrey G. G.
    Hauptman, Jason S. S.
    [J]. PEDIATRIC NEUROSURGERY, 2023, 58 (03) : 150 - 159
  • [2] Pharmacological treatment strategies for subependymal giant cell astrocytoma (SEGA)
    Ebrahimi-Fakhari, Daniel
    Franz, David Neal
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (11) : 1329 - 1336
  • [3] Hydrocephalus in patients with vestibular schwannoma
    Fairhead, Rory
    Harris, Lauren
    Shoakazemi, Alireza
    Pollock, Jonathan
    [J]. ACTA NEUROCHIRURGICA, 2023, 165 (12) : 4169 - 4174
  • [4] Surgery for subependymal giant cell astrocytomas in children with tuberous sclerosis complex
    Fohlen, Martine
    Ferrand-Sorbets, Sarah
    Delalande, Olivier
    Dorfmueller, Georg
    [J]. CHILDS NERVOUS SYSTEM, 2018, 34 (08) : 1511 - 1519
  • [5] The CARE guidelines: consensus-based clinical case report guideline development
    Gagnier, Joel J.
    Kienle, Gunver
    Altman, Douglas G.
    Moher, David
    Sox, Harold
    Riley, David
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2014, 67 (01) : 46 - 51
  • [6] Navigating Uncharted Waters: Comparative Analysis of Clinical Progression and Outcomes in Vestibular Schwannoma Patients with Papilledema and without Hydrocephalus, Versus Those without Papilledema and Hydrocephalus: A Comprehensive Institutional Insight
    Jha, Vikas Chandra
    Jain, Rahul
    Sinha, Vivek Saran
    Kumar, Nitish
    Verma, Gaurav
    Maurya, Vijendra kumar
    [J]. WORLD NEUROSURGERY, 2024, 184 : e743 - e753
  • [7] Kasper Ekkehard, 2017, Asian J Neurosurg, V12, P746, DOI 10.4103/ajns.AJNS_231_16
  • [8] Surgical Treatment of Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex Patients
    Kotulska, Katarzyna
    Borkowska, Julita
    Roszkowski, Marcin
    Mandera, Marek
    Daszkiewicz, Pawel
    Drabik, Krzysztof
    Jurkiewicz, Elzbieta
    Larysz-Brysz, Magdalena
    Nowak, Katarzyna
    Grajkowska, Wieslawa
    Domanska-Pakiela, Dorota
    Jozwiak, Sergiusz
    [J]. PEDIATRIC NEUROLOGY, 2014, 50 (04) : 307 - 312
  • [9] Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis comparable with mechanisms seen in inflammatory pathways? Part I: historical observations and clinical perspectives on the etiology of increased CSF protein levels, CSF clotting, and communicating hydrocephalus: a comprehensive review
    Laviv, Yosef
    Kasper, Burkhard S.
    Kasper, Ekkehard M.
    [J]. NEUROSURGICAL REVIEW, 2018, 41 (04) : 957 - 968
  • [10] Persistent communicating hydrocephalus in adult tuberous sclerosis patients: a possible therapeutic role for everolimus
    Laviv, Yosef
    Jackson, Steven
    Rappaport, Zvi Harry
    [J]. ACTA NEUROCHIRURGICA, 2015, 157 (02) : 241 - 245